These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32349765)

  • 1. The role of complement immune response on artemisinin-based combination therapy in a population from malaria endemic region of Western Kenya.
    Wanjala CNL; Bergmann-Leitner E; Akala HM; Odhiambo G; Ogutu BR; Andagalu B; Kamau E; Ochiel D
    Malar J; 2020 Apr; 19(1):168. PubMed ID: 32349765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host immunity to
    Ataide R; Ashley EA; Powell R; Chan JA; Malloy MJ; O'Flaherty K; Takashima E; Langer C; Tsuboi T; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJ
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3515-3520. PubMed ID: 28289193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Declining Transmission and Immunity to Malaria and Emerging Artemisinin Resistance in Thailand: A Longitudinal Study.
    Ataíde R; Powell R; Moore K; McLean A; Phyo AP; Nair S; White M; Anderson TJ; Beeson JG; Simpson JA; Nosten F; Fowkes FJI
    J Infect Dis; 2017 Sep; 216(6):723-731. PubMed ID: 28934435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials.
    Okell LC; Drakeley CJ; Ghani AC; Bousema T; Sutherland CJ
    Malar J; 2008 Jul; 7():125. PubMed ID: 18613962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.
    Muwanguzi J; Henriques G; Sawa P; Bousema T; Sutherland CJ; Beshir KB
    Malar J; 2016 Jan; 15():36. PubMed ID: 26801909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
    Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
    Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults.
    Dent AE; Bergmann-Leitner ES; Wilson DW; Tisch DJ; Kimmel R; Vulule J; Sumba PO; Beeson JG; Angov E; Moormann AM; Kazura JW
    PLoS One; 2008; 3(10):e3557. PubMed ID: 18958285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991-2019.
    Rathmes G; Rumisha SF; Lucas TCD; Twohig KA; Python A; Nguyen M; Nandi AK; Keddie SH; Collins EL; Rozier JA; Gibson HS; Chestnutt EG; Battle KE; Humphreys GS; Amratia P; Arambepola R; Bertozzi-Villa A; Hancock P; Millar JJ; Symons TL; Bhatt S; Cameron E; Guerin PJ; Gething PW; Weiss DJ
    Malar J; 2020 Oct; 19(1):374. PubMed ID: 33081784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial.
    Byakika-Kibwika P; Nyakato P; Lamorde M; Kiragga AN
    Malar J; 2018 Oct; 17(1):400. PubMed ID: 30376860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.
    O'Flaherty K; Ataíde R; Zaloumis SG; Ashley EA; Powell R; Feng G; Reiling L; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJI
    J Infect Dis; 2019 Aug; 220(7):1178-1187. PubMed ID: 31075171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of malaria prevalence after introduction of artemisinin-combination-therapy in Mbeya Region, Tanzania: results from a cohort study with 6773 participants.
    Froeschl G; Saathoff E; Kroidl I; Berens-Riha N; Clowes P; Maboko L; Assisya W; Mwalongo W; Gerhardt M; Ntinginya EN; Hoelscher M
    Malar J; 2018 Jun; 17(1):245. PubMed ID: 29940968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?
    Sutherland CJ; Babiker H; Mackinnon MJ; Ranford-Cartwright L; El Sayed BB
    Parasitology; 2011 Oct; 138(12):1459-68. PubMed ID: 21810298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.
    Kiaco K; Teixeira J; Machado M; do Rosário V; Lopes D
    Malar J; 2015 Dec; 14():504. PubMed ID: 26670642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) in Treating Uncomplicated P. falciparum Malaria in Metehara, Eastern Ethiopia: Regulatory Clinical Study.
    Nega D; Assefa A; Mohamed H; Solomon H; Woyessa A; Assefa Y; Kebede A; Kassa M
    PLoS One; 2016; 11(4):e0154618. PubMed ID: 27128799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity.
    Okell LC; Drakeley CJ; Bousema T; Whitty CJ; Ghani AC
    PLoS Med; 2008 Nov; 5(11):e226; discussion e226. PubMed ID: 19067479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of submicroscopic infections and gametocyte carriage of Plasmodium falciparum during peak malaria transmission season in a community-based cross-sectional survey in western Kenya, 2012.
    Zhou Z; Mitchell RM; Kariuki S; Odero C; Otieno P; Otieno K; Onyona P; Were V; Wiegand RE; Gimnig JE; Walker ED; Desai M; Shi YP
    Malar J; 2016 Aug; 15(1):421. PubMed ID: 27543112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Between Malaria-Specific Antibody Profiles and Responses to Artemisinin Combination Therapy for Treatment of Uncomplicated Malaria in Western Kenya.
    Odhiambo G; Bergmann-Leitner E; Maraka M; Wanjala CNL; Duncan E; Waitumbi J; Andagalu B; Jura WGZO; Dutta S; Angov E; Ogutu BR; Kamau E; Ochiel D
    J Infect Dis; 2019 May; 219(12):1969-1979. PubMed ID: 30649381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger.
    Grandesso F; Guindo O; Woi Messe L; Makarimi R; Traore A; Dama S; Laminou IM; Rigal J; de Smet M; Ouwe Missi Oukem-Boyer O; Doumbo OK; Djimdé A; Etard JF
    Malar J; 2018 Jan; 17(1):52. PubMed ID: 29370844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Enfranze, north-west Ethiopia.
    Getnet G; Fola AA; Alemu A; Getie S; Fuehrer HP; Noedl H
    Malar J; 2015 Jun; 14():258. PubMed ID: 26105035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.